Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background and Purpose Centronuclear myopathy (CNM) is characterized by the presenceof central nuclei within a large number of muscle fibers. Mutations of the dynamin 2 gene (DNM2)are common causes of autosomal dominant or sporadic CNM. The aim of this study was to characterize the clinical and pathological features of CNM relative to the presence of DNM2 mutations. Methods Six patients with clinical and pathological features of CNM were recruited. Detailedclinical and pathological findings were analyzed according to the presence of DNM2 mutations. Results We detected DNM2 mutations in four of the six sporadic CNM patients, and identifiedthe following distinct clinical and pathological features in those patients with DNM2 mutations:preferential involvement of the distal lower limbs, typical nuclear centralization, and radially distributed sarcoplasmic strands in muscle pathology. In contrast, those without DNM2 mutationsexhibited rather diffuse muscular involvement, and nuclear internalization and myofibrillar disorganization were more pronounced features of their muscle pathology. Conclusions These findings suggest the presence of specific features in Korean CNM patients. A detailed clinical and pathological examination of CNM patients would be helpful for molecular genetic analyses of this condition.
Abstract
Background and Purpose Centronuclear myopathy (CNM) is characterized by the presenceof central nuclei within a large number of muscle fibers. Mutations of the dynamin 2 gene (DNM2)are common causes of autosomal dominant or sporadic CNM. The aim of this study was to characterize the clinical and pathological features of CNM relative to the presence of DNM2 mutations. Methods Six patients with clinical and pathological features of CNM were recruited. Detailedclinical and pathological findings were analyzed according to the presence of DNM2 mutations. Results We detected DNM2 mutations in four of the six sporadic CNM patients, and identifiedthe following distinct clinical and pathological features in those patients with DNM2 mutations:preferential involvement of the distal lower limbs, typical nuclear centralization, and radially distributed sarcoplasmic strands in muscle pathology. In contrast, those without DNM2 mutationsexhibited rather diffuse muscular involvement, and nuclear internalization and myofibrillar disorganization were more pronounced features of their muscle pathology. Conclusions These findings suggest the presence of specific features in Korean CNM patients. A detailed clinical and pathological examination of CNM patients would be helpful for molecular genetic analyses of this condition.
참고문헌 (19)
- Spiro AJ, "Myotubular myopathy. Persistence of fetal muscle in an adolescent boy", Arch Neurol, 14, pp.1~14 (1966)
- Laporte J, "A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast", Nat Genet, 13, pp.175~182 (1996)
- Bitoun M, "Mutations in dynamin 2 cause dominant centronuclear myopathy", Nat Genet, 37, pp.1207~1209 (2005)
- Nicot AS, "Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy", Nat Genet, 39, pp.1134~1139 (2007)
- Wilmshurst JM, "RYR1 mutations are a common cause of congenital myopathies with central nuclei", Ann Neurol, 68, pp.717~726 (2010)
- Züchner S, "Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease", Nat Genet, 37, pp.289~294 (2005)
- Jeannet PY, "Clinical and histologic findings in autosomal centronuclear myopathy", Neurology, 62, pp.1484~1490 (2004)
- Melberg A, "Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset", Neuromuscul Disord, 20, pp.53~56 (2010)
- Bitoun M, "Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis", Hum Mutat, 30, pp.1419~1427 (2009)
- Susman RD, "Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy", Neuromuscul Disord, 20, pp.229~237 (2010)
- Böhm J, "Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy", Hum Mutat, 33, pp.949~959 (2012)
- Koutsopoulos OS, "Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy", PLoS One, 6, pp.e27498~ (2011)
- Fischer D, "Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy", Brain, 129, pp.1463~1469 (2006)
- Catteruccia M, "Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort", Neuromuscul Disord, 23, pp.229~238 (2013)
- Bitoun M, "Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset", Ann Neurol, 62, pp.666~670 (2007)
- Hanisch F, "Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations", J Neurol, 258, pp.1085~1090 (2011)
- Romero NB, "Centronuclear myopathies: a widening concept", Neuromuscul Disord, 20, pp.223~228 (2010)
- Bevilacqua JA, "“Necklace” fibers, a new histological marker of lateonset MTM1-related centronuclear myopathy", Acta Neuropathol, 117, pp.283~291 (2009)
- Mori-Yoshimura M, "Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2", Clin Neurol Neurosurg, 114, pp.678~683 (2012)